From Pharmacy Drug Guide
Novartis patient assistance programs help patients in need of financial assistance save money on Novartis medications. In order to qualify for patient assistance from Novartis, patients must be Unites States residents, cannot have public prescription coverage, although Medicare may be okay, and must provide proof of income within the program's specified guidelines.
The programs cover prescription drugs for a variety of illnesses such as high blood pressure, cancer, multiple sclerosis, attention deficit hyperactivity disorder (ADHD), seizures, fungal infections and more. Upon approval, Novartis will ship the covered medicine to doctors' offices, where patients can pick them up. Patients are required to fill out a separate application for each drug that they need.
|Assistance provided by||Novartis Patient Assistance Foundation|
|Medicare eligible?||In some cases|
|Enrollment requirements||Paperwork for enrollment can be sent by mail or fax|
|Benefits||Medicines are free of charge, with a low copay for drug card users|
|Eligibility||U.S. resident, no private or public insurance coverage, proof of income within program's guidelines|
|Disclaimer||The information provided by PharmacyDrugGuide.com is not a substitute for professional medical advice, diagnosis, or treatment. Do not take any action based on the information on this page without consulting a physician.|
Novartis Pharmaceuticals Corporation (NPC) is a United States affiliate of the Switzerland-based company Novartis AG. All information contained on this page applies to the U.S. affiliate. Novartis is responsible for researching, developing, and selling new pharmaceuticals to treat a number of diseases. André Wyss is the president of the company.
The company was formed in 1996 with the merger of two other pharmaceutical companies: Sandoz and Ciba-Geigy. Sandoz was founded in 1886, while Ciba-Geigy was formed in 1970 with the merger of Geigy and Ciba. Geigy entered the pharmaceuticals world in the 1700s, while Ciba was founded in 1859. Today, Novartis conducts most of its new drug research out of the Novartis Institutes for BioMedical Research, which is based in Cambridge, Massachusetts.
About Novartis Patient Assistance Programs
Novartis Patient Assistance Programs are for patients who have no private or public insurance coverage other than Medicare in some cases, reside in the United States and have limited family income. Benefits for qualifying patients include free prescription medication from Novartis, although a small copay fee does apply for products that require a pharmacy card.
Income requirements vary according to medication type. For general and primary care medications, eligible patients or their households must earn less than 250 percent of the federal poverty level. For antipsychotics, transplant drugs, cystic fibrosis medicines and hepatitis B treatments, eligible patients must earn less than 300 percent of the federal poverty level. For oncology and multiple sclerosis treatments, eligible patients must earn less than 500 percent of the federal poverty level.
Patients may start the enrollment process by calling Novartis directly at 800-277-2254 or visiting the program website. The application procedure will vary depending on the drug the patient is applying for, and may require more extensive assistance from the patient's physician. Patients may mail applications to Novartis or fax them in. The company warns that any third party that charges patients to enroll in Novartis patient assistance programs is not affiliated with the pharmaceutical company in any way.
Novartis also offers an online library of information for a wide variety of medical conditions, such as Alzheimer's disease, attention deficit hyperactivity disorder, heart disease, bone disease, multiple sclerosis, cancer, diabetes, high blood pressure, shingles and others. They also provide information for senior citizens on how to stay healthy.
Novartis routinely conducts studies on new medicines, and invites qualifying patients to volunteer for this research. Doing so may provide an opportunity to try drugs at no cost.
Novartis Patient Assistance Program Covered Medications
Novartis medications eligible for help by the Novartis Patient Assistance Foundation, inc. change from time to time. These drugs are currently covered:
- Afinitor®, everolimus
- Amturnide®, aliskiren
- Clozaril®, clozapine
- Coartem®, everolimus
- Comtan®, entacapone tablets
- Diovan®, valsartan hydrochloride
- Diovan HTC®
- Enoxaparin sodium
- Exelon®, rivastigmine tartrate
- Exforge HCT®, amlodippine, valsartan, and hydrochlorothiozide
- Exjade®, deferasirox
- Extavia®, interferon beta-1b
- Fanapt®, iloperidone
- Focalin XR®, dexmethylphenidate hydrochloride
- Gilenya®, fingolimod
- Gleevec®, imatinib mesylate capsules
- Ilaris®, canakinumab
- Lamisil® Oral Granules terbinafine hydrochloride
- Myfortic®, mycophenolic acid)
- Neoral®, cyclosporine soft gelatin capsule, USP
- Reclast®, zolendronic acid
- Ritalin®, methylphenidate HCl
- Sandimmune®, cyclosporine
- Sandostatin LAR® Depot
- Tasigna®, nilotinib
- Tegretol®, carbamazepine
- Tekamlo®, aliskiren and amlodipine
- Tekturna®, aliskiren and hydrochlorothiazide
- TOBI®, tobramycin inhalation solution USP
- Trileptal®, oxcarbazepine
- Tyzeka®, telbivudine
About Patient Assistance Programs
Also See: Patient Assistance Programs, Prevacid Coupons, Nexium Coupons, Lotrel Side Effects, Walgreens Prescription Club, Novartis Recall, Eli Lilly Patient Assistance Programs, Sanofi Patient Assistance Programs, Merck Patient Assistance Programs